Instead Milestones

February 2009
Dr Steven Brody, M.D. and Dr Kenneth Herbst, M.D. join Instead Advisory Board.

May 2006
Instead licenses the FemCap (www.femcap.com), the only FDA approved cervical contraceptive barrier available since the daiphragm.

February 2005
Former US Secretary of Health & Human Services, Tommy Thompson, joined Instead Advisory Board.

December 2004
Postcoital Study showing Amphora effectiveness equivalent to N-9 published in Conception. Study funded by CONRAD.

July 2004
US FDA granted Instead 510k medical device clearance for Amphora to be marketed as a personal lubricant.

March 2004
US patent granted for Amphora

January2003
Rush University grants Instead exclusive worldwide rights to Amphora.

March 2000
Amphora-related findings presented at the first international conference devoted solely to the study of microbicides, Microbicides 2000.

1999
Amphora Vaginal Tolerance Data published in Conception.